Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?
Clin Infect Dis
.
2017 Aug 15;65(4):702-703.
doi: 10.1093/cid/cix393.
Authors
Nenad Macesic
1
2
,
Brian Nelson
3
,
Anne-Catrin Uhlemann
1
Affiliations
1
Division of Infectious Diseases, Columbia University Medical Center, New York City.
2
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
3
Department of Pharmacy, Columbia University Medical Center/New York Presbyterian Hospital.
PMID:
29017267
PMCID:
PMC5850417
DOI:
10.1093/cid/cix393
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Carbapenem-Resistant Enterobacteriaceae*
Carbapenems
Colistin
Humans
Klebsiella Infections*
Klebsiella pneumoniae
Substances
Carbapenems
Colistin
Grants and funding
R01 AI116939/AI/NIAID NIH HHS/United States